Las Vegas, NV -- (SBWIRE) -- 01/25/2013 -- PennyStockParlay.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Zion Oil & Gas, Inc. (NASDAQ:ZN) shares declined 23.27% to $1.22 in the morning hour. The company will unveil its latest earnings on Monday, January 28, 2013. The average analyst estimate is for profit of 41 cents per share, a rise of 70.8% from the company’s actual earnings for the year-ago quarter.
Should Investors Buy ZN After The Recent Drop? Find Out Here
LDK Solar Co., Ltd (ADR) (NYSE:LDK) shares increased 0.53% to $1.88 after the company announced that it has entered into a share purchase agreement dated January 21, 2013 with Fulai Investments Limited, which has agreed to purchase 17,000,000 newly issued ordinary shares of LDK Solar, at a purchase price of US$1.83 per share with an aggregate purchase price of US$31,110,000, subject to the terms and conditions of the share purchase agreement, including a lock-up for 180 days from the closing date of the contemplated transactions.
We Have A Free Trend Analysis on LDK, Find Out Here
Michael Kors Holdings Ltd (NYSE:KORS) shares climbed 0.60% to $57.07. The company announced that it plans to report its third quarter fiscal 2013 financial results on Tuesday, February 12, 2013, before the market opens. The Company also plans to hold a conference call to discuss its financial results the same day at 8:00 a.m. ET.
Additionally, Zacks Investment Research, on Jan. 21, upgraded Michael Kors to a Zacks Rank #1 (Strong Buy) on Jan 19. Strong demand for brands and assortments, along with innovative fashion designs are the rank drivers for this stock.
Get More latest News, Rumors and Updates On KORS Here
Cirrus Logic, Inc. (NASDAQ:CRUS) shares increased 7.64% to $28.75 after the company posted third-quarter net income of $67.86 million or $0.99 per share, up from $16.73 million or $0.25 per share in the same quarter last year. Adjusted income was $112.80 million or $1.64 per share, compared to adjusted income of $28.85 million or $0.43 per share in the same period last year. Analysts expected the company to earn $1.41 per share for the quarter. Net revenues for the quarter more than doubled to $310.13 million from $122.37 million in the same period last year. Analysts had a consensus revenue estimate of $285.96 million.
How To Trade CRUS Now After The Recent Volatile Moves? Find Out Here
Cell Therapeutics Inc (NASDAQ:CTIC) shares climbed 3.52% to $1.47. The company, on Jan. 18, said it will pay $19 million and adopt new corporate governance measures under a settlement that ends nearly three years of litigation with shareholders. The shareholder lawsuit had accused the Seattle-based biotech of not accurately disclosing information about Pixantrone, the company’s drug for non-Hodgkin lymphoma.
Don’t Forget To Get Your Free Trend Analysis Here
PennyStockParlay.com has been successful in bringing Stock Parlay members with top penny stock newsletter. Stock Parlay’s staff and penny stocks exploration methods have proved 100% accurate in finding the best penny stocks move in e-mail alerts. PennyStockParlay.com works all day and night to find the best penny stock picks portfolio through penny stock newsletter. PennyStockParlay.com has kept winning members with top penny stock newsletter.
The assembled information disseminated by PennyStockParlay.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. PennyStockParlay.com does expect that investors will buy and sell securities based on information assembled and presented in PennyStockParlay.com. Please always do due diligence; consult a financial advisor before buying or selling stocks.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)